Progenics Pharmaceuticals Crosses Above its 10-day MA (PGNX)
Today, shares of Progenics Pharmaceuticals (NASDAQ:PGNX) have crossed bullishly above their 10-day moving average of $5.31 on a volume of 9.4 million shares. Swing traders may find an opportunity for a long position, as such a crossover often suggests higher prices in the near term.
In the past 52 weeks, shares of Progenics Pharmaceuticals have traded between a low of $3.61 and a high of $11.15 and are now at $6.42, which is 78% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.1% while the 200-day MA has slid 1%.
SmarTrend is monitoring the recent change of momentum in Progenics Pharmaceuticals. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Progenics Pharmaceuticals in search of a potential trend change.
Keywords: moving crosses progenics pharmaceuticals